New pathogenic insights in chronic urticaria

Professor Ana Giménez-Arnau chaired a very interesting session about chronic urticaria and the new pathogenic insights about it at the recent EADV symposium in Ljubljana.

Treatment options of chronic urticaria

Professor Margarida Gonçalo shared with us one of the session of the recent EADV Symposium took place in Ljubljana. The topic was chronic urticaria.

Psoriasis is a systemic disease

Prof. Gisondi discussed the common genetic background linking psoriasis and its comorbidities and reviewed specific overlapping genes between psoriasis and these comorbidities, including obesity, diabetes, and myocardial infarction. He also noted how inflammatory mediators released from psoriatic lesions can have systemic effects, including effects on the liver, adipose tissue, and skeletal muscle that contribute to endothelial dysfunction and atherosclerosis.

New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers

Researchers have developed a novel allergen-depleted and anti-inflammatory fragrance that can be used in moisturisers for people with extremely dry, xerotic skin. Beiersdorf researchers in Germany report the results of two tests proving the fragrance is anti-inflammatory at today's 29th EADV Congress, EADV Virtual.

New evidence shows that systemic inflammation in psoriasis can be treated orally with a non-living strain of a commensal microbe

New data published shows the first clinical evidence of modulating systemic inflammation by oral delivery of a non-living single strain commensal microbe. This new therapeutic class brings hope for a completely new way of treating this debilitating skin condition.

New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic

New research launched at the 29th EADV Congress, has found that despite the COVID-19 lockdown restrictions, diagnosis of sexually transmitted infections, including gonorrhoea, secondary syphilis and mycoplasma genitalium, have increased.

New analysis reveals ‘long-hauler’ COVID-19 patients with prolonged skin symptoms - Lessons from the International COVID-19 Dermatology Registry

Some COVID-19 patients experience long-lasting skin symptoms that vary according to type of COVID-19 skin rash, a late-breaking abstract at the 29th EADV Congress, EADV Virtual.

Urban living decreases skin bacterial diversity and why is it a problem

Urbanisation is associated with reduced outdoor exposure, increased contact with housing materials, antimicrobials and cleaning products, and increased exposure to synthetic chemical diversity. Through urbanisation, the natural human and plant-based molecules on the hands and skin are largely replaced by synthetic and cosmetic ingredients with an increase in potentially pathogenic bacteria, stress-tolerant bacteria, potentially pathogenic fungi and fungal biomass. These can have a profound impact on skin health and can be associated with typical Western skin pathologies.

Contact dermatitis: New allergens

Professor Margarida Gonçalo speaks about the novelties in the treatment of contact dermatitis.

Hidradenitis suppurativa

Professor Hessel van der Zee speaks about the novelties in the treatment of hidradenitis suppurativa.

Moderate psoriasis: a journey towards patient-centred care

Professor Jose-Manuel Carrascosa speaks about the novelties in the treatment of moderate psoriasis.

Emerging treatments for onychomycosis

Professor Ditte Marie Saunte speaks about the novelties in the treatment of onychomycosis.

Primay results on acne exposome: real life data

Poor dietary habits, increased stress and harsh skincare routines are among the most significant factors associated with acne, a new study has found.

Safety and efficacy of the oral JAK3/TEC inhibitor PF-06651600 and the oral TYK2/JAK1 inhibitor PF-06700841 in a withdrawal/retreatment extension study in patients with alopecia areata

Evidence is mounting that drugs inhibiting Janus kinases (JAKs) may be effective in the treatment of a variety of dermatologic diseases.  

Highlights of the laser session at EADV 2019

Professor Pablo Boixeda speaks about the novelties announced of the laser sessions at the EADV 2019.

International landscape of therapies in CTCL